First drug for rare skin cancer wins approval | Formulary Journal

FDA approved the first treatment for metastatic Merkel cell carcinoma (MCC), a rare, aggressive skin cancer. The agency granted accelerated approval to avelumab (Bavencio, EMD Serono) for the trea

Source: First drug for rare skin cancer wins approval | Formulary Journal

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s